       Document 0968
 DOCN  M9620968
 TI    An open label, phase I/II clinical trial to evaluate the safety and
       biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector)
       in HIV-1-infected subjects.
 DT    9602
 AU    Haubrich R; McCutchan JA; Holdredge R; Heiner L; Merritt J; Merchant B;
       UCSD Treatment Center 92103-6325, USA.
 SO    Hum Gene Ther. 1995 Jul;6(7):941-55. Unique Identifier : AIDSLINE
       MED/96097136
 DE    Clinical Protocols  Female  Gene Products, env/*GENETICS/THERAPEUTIC USE
       Gene Products, rev/*GENETICS/THERAPEUTIC USE  *Gene Therapy  *Genetic
       Vectors  Human  HIV Infections/*THERAPY  HIV-1/*GENETICS  Male  Risk
       Factors  Safety  CLINICAL TRIAL  CLINICAL TRIAL, PHASE I  CLINICAL
       TRIAL, PHASE II  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

